Cyclo Therapeutics, Inc. 8-K Report: Key Updates as of April 20, 2023

Here are the key insights extracted from the provided section of the financial report for Cyclo Therapeutics, Inc. as of April 20, 2023:

1. Entity Information:

• Name: Cyclo Therapeutics, Inc.
• CIK Number: 0000922247
• Incorporation State: Nevada (NV)
• Address: 6714 NW 16th Street Suite B, Gainesville, FL 32653
• Phone Number: 386-418-8060

2. Filing Information:

• Form Type: 8-K (Current Report)
• Filing Date: April 20, 2023

3. Stock Information:

• Common Stock:
• • Par Value: $0.0001 per share
  • Ticker Symbol: CYTH
  • Exchange: NASDAQ
• Warrants:
• • Ticker Symbol: CYTHW
  • Exchange: NASDAQ

4. Reporting Context:

• The report specifies the context for common stock and warrants to purchase common stock, indicating that the company may be addressing changes or updates relevant to these financial instruments.

5. Dimensions and Members:

• The report references specific dimensions related to stock classes, indicating that it includes explicit members for common stock and warrants, suggesting a detailed breakdown of the equity structure.

Summary:

Cyclo Therapeutics is reporting under SEC Form 8-K, covering important updates as of April 20, 2023. The company has common stock with a low par value and is publicly traded on NASDAQ under the ticker CYTH, alongside warrants traded under CYTHW. The document also highlights the company's context for reporting dimensions related to its stock classes, which may be important for understanding the financial condition or any recent changes in equity.